‘He’s playing well, but …’: Sourav Ganguly weighs in on Dhruv Jurel’s Test selection amid growing clamour for inclusion

Sourav Ganguly acknowledged Dhruv Jurel’s impressive form but noted the challenge of breaking into India’s settled Test lineup. He highlighted the competition for the number three spot, with Jurel vying against other in-form players. Ganguly also backed India as favourites at home due to their strong spin attack and recent performances.

Read More

Explained: FDA removes warning label from hormone treatments for menopause; what happens now (risk factors and safe practice tips)

The FDA is removing the “black box” warning from many hormone therapies for menopause symptoms, citing new research showing lower risks for women under 60 or within 10 years of menopause. This shift encourages individualized treatment decisions, balancing benefits against potential risks based on a woman’s health profile.

Read More